Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine in the Prevention of Ischemia-Reperfusion Injury During Liver Transplantation
Stock Information for Revive Therapeutics Ltd
Loading
Please wait while we load your information from QuoteMedia.